Management of Atrial Fibrillation
The Course is designed to help Cardiologists and General Physicians in understanding the Management of Atrial Fibrillation. At the end of this course, the panel discussion of renowned doctors will help participants get insights on various aspects of Atrial Fibrillation.
Enroll in DM003
Offered by docmode
Share your Case Studies
Come join our "Learn as you Teach" initiative to democratise healthcare learning by submitting your unique & interesting Case-Studies which will be reviewed by our global medical fraternity as well as an opportunity to be published in leading research journals.
About this Course
Objective of the course: To be able to Diagnose and Treat Atrial Fibrillation
Atrial fibrillation (AF) is the most common type of arrhythmia. Disorder in the heart's electrical system is the cause for AF.It can lead to an increased risk of stroke.
In many patients, it can also cause chest pain, heart attack, or heart failure.
Atrial fibrillation is the most common heart rhythm disturbance, affecting around 1 million people.It can affect adults of any age, but it's more common in older people. It affects about 7 in 100 people aged over 65. More men than women have atrial fibrillation.
Atrial fibrillation is more likely to occur in people with other conditions, such as high blood pressure (Hypertension), Atherosclerosis or a Heart valve problem.
This course will enhance the Management of Atrial Fibrillation and Antithrombic therapy post PCI of Afib patients.
Meet the Instructor
Prof. Augustus Oliver GrantDuke University School of Medicine.
Prof.Grant attended the University of Edinburgh in Scotland where he earned undergraduate and Medical degrees, and then went on to the University of California at San Francisco to study pharmacology, completing a doctorate in 1975.He joining the faculty at Duke's School of Medicine in 1980.In 2003 Grant was elected president of the American Heart Association (AHA).In his research and clinical practice, Prof.Grant has focused on the understanding and treatment of patients with cardiac arrhythmias.Prof.Grant's work aims to identify new ways to diagnose, treat, and prevent arrhythmias.
Prof. Christopher P. CannonHarvard Medical School
Dr. Cannon is a professor of medicine at Harvard Medical School, and senior physician in the Cardiovascular Division at Brigham and Women’s Hospital. He earned his MD from Columbia University College of Physicians and Surgeons in New York and did internal medicine residency at Columbia Presbyterian Medical Center.He has been principal investigator of more than 20 multicenter clinical trials, including TACTICS-TIMI 18 and PROVE IT, and the IMPROVE IT trials. Dr. Cannon serves as Executive Director of Cardiometabolic Trials at The Baim Institute. He is leading the RE-DUAL PCI trial, studying novel anticoagulant strategies in patients with atrial fibrillation undergoing stenting,